Literature DB >> 33993458

Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication.

Lokeswara Bala Krishna Sunnam1, Anand K Kondapi2.   

Abstract

Topoisomerase II beta (Topo IIβ) is one of the two isoforms of type II topoisomerases present in higher eukaryotes. This 180 kDa nuclear protein involves in different cellular processes like transcription, recombination, etc., apart from its normal topological functions. Previously, we have reported the association of this isoform along with the other isoform topoisomerase II alpha (Topo IIα) with HIV-1 reverse transcription complex and the downregulation of Topo IIβ expression resulted in incomplete reverse transcription. In this study, we have tested the Topo IIβ specific siRNA delivery using protein nanoparticles prepared with c-terminal domine of transferrin (c-ter) for the first time. Results show that, c-ter nanoparticles resemble apotransferrin nanoparticles in drug holding capability and drug delivery but with small in size. Topo IIβ specific siRNA delivered in the form of c-ter nanoformulation resulted in knockdown of Topo IIβ expression for the prolonged periods and which intern resulted in decreased viral replication of HIV-1.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apotransferrin; Gene silencing; HIV-1; Nanoparticles; Topoisomerase IIβ; siRNA

Mesh:

Substances:

Year:  2021        PMID: 33993458     DOI: 10.1007/s12033-021-00334-7

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  30 in total

1.  Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis.

Authors:  C A Johnson; K Padget; C A Austin; B M Turner
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

2.  Involvement of DNA topoisomerase IIbeta in neuronal differentiation.

Authors:  K Tsutsui; K Tsutsui; K Sano; A Kikuchi; A Tokunaga
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

3.  Histone deacetylase interacts directly with DNA topoisomerase II.

Authors:  S C Tsai; N Valkov; W M Yang; J Gump; D Sullivan; E Seto
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

4.  Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta.

Authors:  Yi Lisa Lyu; James C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

5.  Topoisomerase II levels during granulocytic maturation in vitro and in vivo.

Authors:  S H Kaufmann; S J McLaughlin; M B Kastan; L F Liu; J E Karp; P J Burke
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

6.  Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.

Authors:  K Chikamori; J E Hill; D R Grabowski; E Zarkhin; A G Grozav; S A J Vaziri; J Wang; A V Gudkov; L R Rybicki; R M Bukowski; A Yen; M Tanimoto; M K Ganapathi; R Ganapathi
Journal:  Leukemia       Date:  2006-08-17       Impact factor: 11.528

7.  Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.

Authors:  S H Kaufmann; M Charron; P J Burke; J E Karp
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

8.  Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53.

Authors:  I G Cowell; A L Okorokov; S A Cutts; K Padget; M Bell; J Milner; C A Austin
Journal:  Exp Cell Res       Date:  2000-02-25       Impact factor: 3.905

9.  The topoisomerase II-Hsp90 complex: a new chemotherapeutic target?

Authors:  Catherine R Barker; Jane Hamlett; Stephen R Pennington; Francis Burrows; Karen Lundgren; Rachel Lough; Alastair J M Watson; John R Jenkins
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

10.  Modification of DNA topoisomerase II activity via direct interactions with the cyclic adenosine-3',5'-monophosphate response element-binding protein and related transcription factors.

Authors:  D J Kroll; D M Sullivan; A Gutierrez-Hartmann; J P Hoeffler
Journal:  Mol Endocrinol       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.